R
Rosemary Basson
Researcher at University of British Columbia
Publications - 8
Citations - 1840
Rosemary Basson is an academic researcher from University of British Columbia. The author has contributed to research in topics: Sexual dysfunction & Hypoactive sexual desire disorder. The author has an hindex of 8, co-authored 8 publications receiving 1719 citations.
Papers
More filters
Journal ArticleDOI
Report of the international consensus development conference on female sexual dysfunction: definitions and classifications.
Rosemary Basson,Jennifer Berman,Arthur L. Burnett,Leonard R. Derogatis,David M. Ferguson,Jean L. Fourcroy,Irwin Goldstein,Alessandra Graziottin,Julia Heiman,Ellen Laan,Sandra R. Leiblum,Harin Padma-Nathan,Raymond C. Rosen,Kathleen Segraves,R. Taylor Segraves,Ridwan Shabsigh,Marcalee Sipski,Gorm Wagner,Beverly Whipple +18 more
TL;DR: Use of the new female sexual dysfunction diagnostic and classification system based on physiological as well as psychological pathophysiologies, and a personal distress criterion for most diagnostic categories are recommended.
Journal ArticleDOI
Group mindfulness-based therapy significantly improves sexual desire in women.
Lori A. Brotto,Rosemary Basson +1 more
TL;DR: Mindfulness-based group therapy significantly improved sexual desire and other indices of sexual response, and should be considered in the treatment of women's sexual dysfunction.
Journal ArticleDOI
Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder.
Anita H. Clayton,R. Taylor Segraves,Sandra R. Leiblum,Rosemary Basson,Robert Pyke,Dan Cotton,Diane J. Lewis-D'Agostino,Kenneth R. Evans,Terrence Sills,Glen Wunderlich +9 more
TL;DR: The results of the present investigation indicate that the SIDI-F is a reliable and valid measure of HSDD severity, independent of relationship issues.
Journal ArticleDOI
Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications
Rosemary Basson,Jennifer Berman,Arthur L. Burnett,Leonard R. Derogatis,David M. Ferguson,Jean L. Fourcroy,Irwin Goldstein,Alessandra Graziottin,Julia Heiman,Ellen Laan,Sandra R. Leiblum,Harin Padma-Nathan,Raymond C. Rosen,Kathleen Segraves,R. Taylor Segraves,Ridwan Shabsigh,Marcalee Sipski,Gorm Wagner,Beverly Whipple +18 more
TL;DR: Financial interest and/or other relationship with Affiliated Research Centers, Astra, Bayer AG, Bristol-Myers, Eli Lilly, Fournier Group, Glaxo Wellcome, Lilly/ICOS, Matrix Pharma, NexMed, NitroMed, Pentech, Pfizer Inc., Pfizer Canada Ltd., Pfizers UK, Pharmacia & Upjohn, Procter & Gamble, Scherling-Plough, Senetek, Shwarz-Pharma, Sol
Journal ArticleDOI
Role of androgens in women's sexual dysfunction
TL;DR: Significantly lower levels of the two precursor steroids dehydroepiandrosterone sulfate and androstene-3&bgr;,17&bGr;-diol but not the major androgen metabolite ADT-G were found in women with HSDD, and women receiving testosterone therapy should be informed that a deficit of testosterone activity in Women with H SDD has not been identified.